Healthpeak upgraded by Exane BNP Paribas with a new price target
$PEAK
Real Estate Investment Trusts
Real Estate
Exane BNP Paribas upgraded Healthpeak from Underperform to Neutral and set a new price target of $19.00
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 2/12/2024 | $19.00 | Underperform → Neutral | Exane BNP Paribas |
| 1/30/2024 | $21.00 | Hold | Deutsche Bank |
| 1/12/2024 | $20.00 → $23.00 | Sector Perform → Sector Outperform | Scotiabank |
| 11/13/2023 | $17.50 | Neutral → Underperform | BofA Securities |
| 10/11/2023 | $18.00 | Underperform | Exane BNP Paribas |
| 10/3/2023 | $19.00 | Neutral | Wedbush |
| 4/24/2023 | $29.00 → $25.00 | Neutral → Buy | Mizuho |
| 4/20/2023 | $23.00 | Equal Weight | Wells Fargo |